Immediate Impact
50 standout
Citing Papers
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside
2024 Standout
Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician
2024 Standout
Works of Javier Rueda‐Gotor being referenced
Asymmetric dimethylarginine serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy.
2013
SCORE and REGICOR function charts underestimate the cardiovascular risk in Spanish patients with rheumatoid arthritis
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Javier Rueda‐Gotor | 519 | 182 | 160 | 247 | 55 | 813 | |
| Trinitario Pina | 518 | 286 | 236 | 313 | 54 | 937 | |
| José Félix Restrepo | 550 | 129 | 107 | 207 | 66 | 899 | |
| Daiki Nakagomi | 446 | 175 | 105 | 332 | 61 | 864 | |
| Kimihiro Suzuki | 284 | 243 | 103 | 208 | 59 | 850 | |
| Ayşe Çefle | 465 | 256 | 271 | 190 | 88 | 950 | |
| Meral Koniçe | 483 | 227 | 173 | 230 | 38 | 907 | |
| Aşkın Ateş | 307 | 132 | 131 | 235 | 75 | 774 | |
| Bahar Artım-Esen | 480 | 202 | 131 | 178 | 71 | 815 | |
| H. Devilliers | 607 | 200 | 108 | 381 | 66 | 935 | |
| Taro Iwamoto | 490 | 318 | 120 | 190 | 41 | 897 |
All Works
Login with ORCID to disown or claim papers
Loading papers...